Axxcess Wealth Management LLC Sells 747 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Axxcess Wealth Management LLC cut its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 13.5% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 4,802 shares of the financial services provider’s stock after selling 747 shares during the quarter. Axxcess Wealth Management LLC’s holdings in iShares Biotechnology ETF were worth $659,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of IBB. Global Assets Advisory LLC bought a new position in shares of iShares Biotechnology ETF during the 1st quarter worth approximately $66,059,000. BNP Paribas Financial Markets increased its stake in iShares Biotechnology ETF by 25.7% in the 1st quarter. BNP Paribas Financial Markets now owns 2,055,373 shares of the financial services provider’s stock valued at $282,038,000 after buying an additional 420,053 shares during the last quarter. Gray Foundation bought a new stake in iShares Biotechnology ETF during the 4th quarter worth about $17,890,000. Jane Street Group LLC acquired a new position in shares of iShares Biotechnology ETF during the 1st quarter worth about $14,386,000. Finally, Miller Investment Management LP grew its holdings in shares of iShares Biotechnology ETF by 2,394.4% in the 4th quarter. Miller Investment Management LP now owns 90,122 shares of the financial services provider’s stock valued at $12,243,000 after acquiring an additional 86,509 shares in the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 1.3 %

NASDAQ:IBB opened at $149.47 on Friday. iShares Biotechnology ETF has a 52-week low of $111.83 and a 52-week high of $150.57. The stock’s 50-day simple moving average is $145.63 and its 200 day simple moving average is $138.47.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.